logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. A detailed analysis of charges for hematopoietic stem cell transplantation at a children's hospital.

    Article - En anglais

    We analyzed hospital charges for pediatric hematopoietic stem cell transplantation (HSCT) to understand better the medical origin of these charges.

    Forty-nine patients undergoing HSCT at Kosair Children's Hospital between January 1992 and August 1995 had hospital charges analyzed by cost center, donor type and clinical outcome.

    Thirty-three autologous, two syngeneic and 14 allogeneic transplants were performed.

    Twenty-four transplants were performed for hematological malignancies, 22 for solid tumors, and three for non-malignant diseases.

    Pharmaceutical charges comprised the largest single component of total hospital charges (THC), accounting for 38.9%. Room charges were the next largest group at 33.7% of THC.

    Other cost centers, in order of magnitude, were central supply (7.9%), transfusion services (7.5%), laboratory (5.8%), microbiology (3.6%), miscellaneous (1.9%), and radiology (1.4%). Within the pharmaceutical cost center, colony-stimulating factors comprised the largest single item, making up 18% of total pharmacy charges and 7% of THC.

    Antibiotics were the second largest component, at 16% of pharmacy charges and 6% of THC.

    Patients transferred to the intensive care unit (ICU) had charges 68% greater than non-ICU patients.

    Allogeneic transplant patients had THC 35% greater than autologous transplant patients, but also a four-fold greater chance of becoming an ICU patient. (...)

    Mots-clés Pascal : Economie santé, Etats Unis, Amérique du Nord, Amérique, Greffe, Cellule hématopoïétique, Cellule souche, Moelle osseuse, Cancérologie, Pédiatrie, Hôpital, Enfant, Homme, Analyse coût

    Mots-clés Pascal anglais : Health economy, United States, North America, America, Graft, Hematopoietic cell, Stem cell, Bone marrow, Cancerology, Pediatrics, Hospital, Child, Human, Cost analysis

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 98-0124766

    Code Inist : 002B27D02. Création : 22/06/1998.